2002-2007    中山大学临床医学（七年制）本科阶段 医学学士学位

   2007-2009    中山大学肿瘤医院腹科（七年制硕士阶段）肿瘤学硕士学位

   2009-2010    福建医科大学附属协和医院肿瘤内科 医师

   2010-2013    中山大学肿瘤防治中心博士研究生

   2011-2012    美国密西根州Van Andel Research Institute访问学习1年

   2013-2014    中山大学附属第六医院食管胃肠外科 医师    

   2015-2018    中山大学附属第六医院食管胃肠外科 主治医师

   2019-今      中山大学附属第六医院食管胃肠外科 副主任医师

      中国抗癌协会胃癌专业委员会青年委员

      广东省医学会消化道肿瘤学分会青年委员兼秘书

      长期从事临床教学及科研工作，担任《诊断学》教研室秘书，获得中山大学中青年英文授课大赛优胜奖，主持广东省卫生厅基金，中山大学青年培育项目等基金，并参与国家自然科学基金等项目。主持省级以及学校课题各1项，第一作者/通讯作者身份发表SCI论文26篇。

      1. Chen S, Chen DW, Chen XJ, Lin YJ, Xiang J, Peng JS. Postoperative complications and nutritional status between uncut Roux-en-Y anastomosis and Billroth II anastomosis after D2 distal gastrectomy: a study protocol for a multicenter randomized controlled trial. Trials. 2019 Jul 12;20(1):428. doi: 10.1186/s13063-019-3531-0.
 

      2. Chen XJ, Chen YZ, Chen DW, Chen YL, Xiang J, Lin YJ, Chen S, Peng JS. The Development and Future of Digestive Tract Reconstruction after Distal Gastrectomy: A Systemic Review and Meta-Analysis. J Cancer. 2019 Jan 24;10(4):789-798. doi: 10.7150/jca.28843. eCollection 2019.
 

      3.Chen QY, Zhong Q, Wang W, Chen S, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Liu ZY, Zheng CH, Peng JS, Zhou ZW, Huang CM. Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long-Term Outcomes Based on Conditional Survival. Oncologist. 2018 Nov 23. pii: theoncologist.2018-0220. doi: 10.1634/theoncologist.2018-0220.（co-first author）
 

      4. Chen S, Chen XJ, Chen DW, Xiang J, Peng JS. A novel anti-reflux reconstruction after laparoscopic total gastrectomy: jejunal pouch-esophageal anti-reflux anastomosis. Gastroenterol Rep (Oxf). 2018 Aug;6(3):234-238.
 

      5. Chen S, Chen X, Nie R, Ou Yang L, Liu A, Li Y, Zhou Z, Chen Y, Peng J. A nomogram to predict prognosis for gastric cancer with peritoneal dissemination. Chin J Cancer Res. 2018 Aug;30(4):449-459.
 

      6. Nie RC, Yuan SQ, Chen S, Yan SM, Chen YM, Chen XJ, Chen GM, Zhou ZW, Chen YB, Li YF. Bursectomy for advanced gastric cancer: an update meta-analysis. World J Surg Oncol. 2018 Mar 27;16(1):66. （co-first author）
 

      7. Yuan SQ, Nie RC, Chen YM, Qiu HB, Li XP, Chen XJ, XU LP, Yang LF, Sun XW, Li YF, Zhou ZW, Chen S, Chen YB. Glasgow Prognostic Score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seeding. Oncol Lett. 2018 Apr;15(4):4193-4200. (CO-RESPONDING AUTHOR)

      8. Nie RC, Yuan SQ, Li YF, Chen YM, Chen XJ, Zhu BY, Xu LP, Zhou ZW, Chen S, Chen YB. Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis. J Cancer. 2017 Sep 20;8(17):3396-3404.(CO-RESPONDING AUTHOR)

      9. Zhao BW, Chen S, Li YF, Xiang J, Zhou ZW, Peng JS, Chen YB. Low Expression of CDK10 Correlates with Adverse Prognosis in Gastric Carcinoma. J Cancer. 2017 Aug 25;8(15):2907-2914.

      10.  Yuan SQ, Nie RC, Chen S, Chen XJ, Chen YM, Xu LP, Yang LF, Zhou ZW, Peng JS, Chen YB. Selective Gastric Cancer Patients with Peritoneal Seeding Benefit from Gastrectomy after Palliative Chemotherapy: A Propensity Score Matching Analysis. J Cancer. 2017 Jul 20;8(12):2231-2237.

      11.  Shi Chen, Li-Ying Ou-Yang, Run-Cong Nie et al. Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy. Gastroenterol Res Pract. 2017;2017:4928736.

      12.  Shi Chen, Run-Cong Nie, Li-Ying Ou-Yang et al. Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination. World J Surg Oncol. 2017 Feb 23;15(1):52.

      13.  Run-Cong Nie*, Shu-Qiang Yuan,* Shi Chen* et al. Prognostic nutritional index is an independent prognostic factor for gastric cancer patients with peritoneal dissemination. Chin J Cancer Res. 2016 Dec;28(6):570-578. (contributed equally)

      14.  Shi Chen, Run-Cong Nie, Li-Ying Ou-Yang et al. Nomogram analysis and external validation to predict the risk of lymph node metastasis in gastric cancer. Oncotarget. 2017 Feb 14;8(7):11380- 11388.

      15.  Run-Cong Nie*, Shi Chen*, Shu-Qiang Yuan* et al. Significant Role of Palliative Gastrectomy in Selective Gastric Cancer Patients with Peritoneal Dissemination: A Propensity Score Matching Analysis. Ann Surg Oncol. 2016 Nov;23(12):3956-3963. (contributed equally)

      16.  Min Ma*, Shi Chen*, Bao-Yan Zhu et al. The clinical significance and risk factors of solitary lymph node metastasis in gastric cancer. PLoS One. 2015 Jan 29;10(1):e0114939(contributed equally)

      17.  Shi Chen, Jing-Hui Hou, Xing-Yu Feng et al. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma. J Surg Oncol. 2013 Jun;107(8):799-806.

      18.  Shi Chen, Xing-Yu Feng, Yuan-Fang Li et al. The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy. J Surg Oncol. 2013 May;107(6):641-5.

      19.  Shi Chen, Bai-Wei Zhao,Ying-Bo Chen et al. The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients:  Results of a Study of 1,101 Patients. PLoS one, 2012;7(11):e49424..

      20.  Shi Chen, Ying-Bo Chen, Yuan-Fang Li et al. Normal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients. World J Gastroenterol. 2012 Aug 7;18(29):3910-6.

      21.  Shi Chen, Yuan-Fang Li, Xing-Yu Feng et al. Significance of palliative gastrectomy for late-stage gastric cancer patients. Accepted by Journal of Surgical Oncology, 2012.

      22.  CHEN Shi, CAI Mu-Yan, CHEN Ying-Bo, et al. Serosa-penetration in human T4aN0M0 gastric carcinoma correlates with worse prognosis after D2 gastrectomy. Chin Med J (Engl). 2012 Mar;125(6):1158-62.

      23.  Shi Chen, Ying-Bo Chen, Zhi-Wei Zhou et al. No Survival Benefit From Post- operative Adjuvant Chemotherapy After D2 Radical Resection for the Patients With Stage II Gastric Cancer. Am J Clin Oncol. 2011 Jun;34(3):309-13.

      24.  Shi Chen, Xing-Yu Feng, Yuan-Fang Li, et al. Efficacy and safety of XELOX and FOLFOX6 adjuvant chemotherapy following radical total gastrectomy. ONCOLOGY LETTERS 3: 781-786, 2012

      2018年 CSCO 35under35大赛  最具潜力青年肿瘤医生

      2019年 中国抗癌协会胃癌专业委员会 “未来科学家奖” 优胜奖

      2019年 第五届“协和杯”腹腔镜胃癌手术视频大赛二等奖

      擅长胃癌，肠癌，胃肠道间质瘤以及各种胃肠道罕见肿瘤的诊治，尤其擅长胃癌、肠癌的综合治疗，包括全腹腔镜下胃肠道恶性肿瘤的标准手术治疗，以及胃肠道恶性肿瘤切除术后的消化道重建等技术。